What Are BlueChew Pills and How Do They Work?

BlueChew pills are chewable tablets used to treat erectile dysfunction (ED). They contain the same active ingredients found in well-known ED medications like Viagra, Cialis, and Levitra, but they’re sold as compounded formulations through an online subscription service. You complete a telemedicine consultation, get a prescription from a licensed physician, and receive the tablets by mail each month.

Three Medication Options

BlueChew offers three different active ingredients, each with its own timing profile and duration. The right choice depends on how you want the medication to fit into your life.

Sildenafil is the same active ingredient in Viagra. BlueChew sells it in 30-mg or 45-mg chewable tablets. It takes effect within about 30 to 60 minutes and lasts roughly 4 to 5 hours. This is the most commonly recognized ED medication and works well for planned encounters within a defined window.

Tadalafil is the active ingredient in Cialis. BlueChew offers it in 6-mg or 9-mg tablets. It also kicks in within 30 to 60 minutes (sometimes as quickly as 15 to 16 minutes), but the key difference is duration: tadalafil stays active for 17 to 21 hours. That longer window means less pressure to time things precisely, which is why it’s sometimes called “the weekend pill.”

Vardenafil is the active ingredient in Levitra. BlueChew sells it in 8-mg tablets. Its onset and duration are similar to sildenafil, working within 30 to 60 minutes and lasting about 4 to 5 hours.

How These Medications Work

All three BlueChew options belong to a class called PDE5 inhibitors. They don’t create an erection on their own. They enhance your body’s natural response to sexual arousal.

Here’s the basic biology: when you’re sexually stimulated, nerve endings in the penis release a chemical signal called nitric oxide. That signal triggers a chain reaction that produces a molecule called cGMP, which relaxes the smooth muscle in blood vessel walls. Blood flows in, the tissue expands, and you get an erection. Normally, an enzyme called PDE5 breaks down cGMP fairly quickly, which is part of why erections naturally subside. In men with ED, this breakdown can happen too fast or the whole process doesn’t generate enough cGMP to begin with.

PDE5 inhibitors block that cleanup enzyme, allowing cGMP to build up to higher levels and stick around longer. The result is stronger, more sustained blood flow in response to arousal. Without sexual stimulation, the medication does very little on its own.

Why They’re Chewable

The chewable format is one of BlueChew’s main selling points, and it does have a slight practical advantage. A bioavailability study comparing chewable sildenafil tablets to conventional Viagra found that when taken with water, the chewable version reached peak blood levels in about 45 minutes compared to 60 minutes for standard tablets. The total amount of medication absorbed was essentially the same.

One important detail: chewing the tablet without water actually slowed absorption, with peak levels delayed to about 1 hour and 45 minutes and the peak concentration reduced by roughly 22%. So if speed matters, take the chewable with at least a sip of water. Taste masking in the formulation works well. In clinical testing, only about 3% of people who took the chewable with water reported any bitterness.

How the Prescription Process Works

BlueChew operates through telemedicine. You don’t visit a doctor’s office. Instead, you fill out an online health questionnaire that covers your medical history, current medications, cardiovascular health, blood pressure, lifestyle, and the specifics of your ED symptoms. This takes about 10 to 15 minutes.

A licensed physician reviews your information, typically within 24 hours. They evaluate potential drug interactions, contraindications, and which medication and dose make sense for your profile. If approved, you receive an email confirmation with your prescription details. A licensed pharmacy fills the order within 24 to 48 hours, and you can expect delivery in 3 to 5 business days in discreet packaging. Prescriptions ship on a monthly recurring basis as part of the subscription.

Side Effects and Safety Concerns

The most common side effects of PDE5 inhibitors are headache, flushing, nasal congestion, and digestive upset. At standard ED doses, headache affects roughly 11 to 16% of users depending on the medication. These side effects are generally mild and fade as the drug wears off. At higher doses, visual disturbances, dizziness, and drops in blood pressure become more likely.

The most critical safety issue involves nitrate medications. If you take nitroglycerin, isosorbide, or any other nitrate for heart conditions, PDE5 inhibitors are strictly off-limits. Both nitrates and PDE5 inhibitors increase cGMP levels, and combining them can cause a dangerous, sometimes life-threatening drop in blood pressure. The American College of Cardiology and American Heart Association recommend waiting at least 24 hours after taking sildenafil or vardenafil before using any nitrate, and at least 48 hours after tadalafil because of its longer duration.

Recreational “poppers” (amyl nitrate or nitrite) carry the same risk. Combining them with any PDE5 inhibitor can cause severe hypotension.

People taking alpha-blockers for high blood pressure or prostate enlargement also face an elevated risk of significant blood pressure drops when combining them with PDE5 inhibitors. The online questionnaire is designed to screen for these interactions, but accuracy depends on providing complete and honest medical information.

Compounded, Not FDA-Approved

This is an important distinction many people miss. While the active ingredients in BlueChew (sildenafil, tadalafil, vardenafil) are FDA-approved for treating ED in their brand-name forms, BlueChew’s specific tablets are compounded formulations. Compounded drugs are not FDA-approved. They’re mixed by compounding pharmacies rather than manufactured by the pharmaceutical companies that hold FDA approval.

In September 2025, the FDA issued a warning letter to BlueChew’s parent company, Dermacare LLC, for making claims that implied their compounded products were equivalent to FDA-approved medications. The FDA stated that these claims were “false or misleading” and that BlueChew’s products are technically classified as “new drugs” that are “not generally recognized as safe and effective for their labeled uses.” This doesn’t mean the active ingredients don’t work. It means the specific compounded tablets haven’t gone through the FDA’s approval process for manufacturing quality, consistency, and labeling.

For most users, the practical difference is minimal since the active compounds are well-studied. But it’s worth knowing that compounded medications don’t carry the same regulatory oversight as their brand-name counterparts.